Maliyet tasarrufu

Sistemli ve Çok Modlu Yaklaşım

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (yeni pencere açar)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn, DR

Kaynak‎: Anaesthesia 2019;74(12):1534-41.

İndeks‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Kaynak‎: Blood Adv. 2022;6(3):785-92.

İndeks‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (yeni pencere açar)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (yeni pencere açar)

Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL.

Kaynak‎: Transfusion 2017;57(9):2189-96.

İndeks‎: PubMed 28671296

DOI‎: 10.1111/trf.14191

https://www.ncbi.nlm.nih.gov/pubmed/28671296 (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Mehra T, Seifert B, Bravo-Reiter S, Wanner G, Dutkowski P, Holubec T, Moos RM, Volbracht J, Manz MG, Spahn DR

Kaynak‎: Transfusion 2015;55(12):2807-15.

İndeks‎: PubMed 26264557

DOI‎: 10.1111/trf.13260

https://www.ncbi.nlm.nih.gov/pubmed/26264557 (yeni pencere açar)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (yeni pencere açar)

Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C.

Kaynak‎: Transfusion 2010;50(2):487-92.

İndeks‎: PubMed 19804569

DOI‎: 10.1111/j.1537-2995.2009.02413.x

https://www.ncbi.nlm.nih.gov/pubmed/19804569 (yeni pencere açar)

Anemia Management

Should intravenous iron be the standard of care in oncology? (yeni pencere açar)

Auerbach M.

Kaynak‎: J Clin Oncol 2008;26(10):1579-81.

İndeks‎: PubMed 18375888

DOI‎: 10.1200/JCO.2007.15.4609

https://www.ncbi.nlm.nih.gov/pubmed/18375888 (yeni pencere açar)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (yeni pencere açar)

Beverina I, Razionale G, Ranzini M, Aloni A, Finazzi S, Brando B.

Kaynak‎: Blood Transfus 2020;18(2):106-16.

İndeks‎: PubMed 31855149

DOI‎: 10.2450/2019.0248-19

https://www.ncbi.nlm.nih.gov/pubmed/31855149 (yeni pencere açar)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (yeni pencere açar)

Borg S, Glenngård AH, Osterborg A, Persson U.

Kaynak‎: Acta Oncol 2008;47(6):1009-17.

İndeks‎: PubMed 18770060

DOI‎: 10.1080/02841860701744498

https://www.ncbi.nlm.nih.gov/pubmed/18770060 (yeni pencere açar)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (yeni pencere açar)

Deger M, Eisterer W, Kutikova L, Salek S.

Kaynak‎: Support Care Cancer 2013;21(2):485-93.

İndeks‎: PubMed 22825456

DOI‎: 10.1007/s00520-012-1538-0

https://www.ncbi.nlm.nih.gov/pubmed/22825456 (yeni pencere açar)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (yeni pencere açar)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Kaynak‎: Cancer 2013;119(1):107-14.

İndeks‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (yeni pencere açar)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (yeni pencere açar)

Nikolaidi E, Hatzikou M, Geitona M.

Kaynak‎: Cost Eff Resour Alloc 2013;11(1):16.

İndeks‎: PubMed 23870502

DOI‎: 10.1186/1478-7547-11-16

https://www.ncbi.nlm.nih.gov/pubmed/23870502 (yeni pencere açar)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (yeni pencere açar)

Pashos CL, Larholt K, Fraser KA, McKenzie RS, Senbetta M, Piech CT.

Kaynak‎: Support Care Cancer 2012;20(1):159-65.

İndeks‎: PubMed 21359879

DOI‎: 10.1007/s00520-010-1083-7

https://www.ncbi.nlm.nih.gov/pubmed/21359879 (yeni pencere açar)

Hemostatik Ajanlar

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (yeni pencere açar)

Guest JF, Watson HG, Limaye S.

Kaynak‎: Clin Ther 2010;32(14):2478-93.

İndeks‎: PubMed 21353116

DOI‎: 10.1016/j.clinthera.2011.01.011

https://www.ncbi.nlm.nih.gov/pubmed/21353116 (yeni pencere açar)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (yeni pencere açar)

Jen H, Shew S.

Kaynak‎: J Pediatr Surg 2008;43(12):2235-8.

İndeks‎: PubMed 19040942

DOI‎: 10.1016/j.jpedsurg.2008.08.053

https://www.ncbi.nlm.nih.gov/pubmed/19040942 (yeni pencere açar)

İşlem/Ameliyat Sırasında Kan Koruma ve Kan Yönetimi

Restrictive blood transfusion practices are associated with improved patient outcomes. (yeni pencere açar)

Goodnough LT, Maggio P, Hadhazy E, Shieh L, Hernandez-Boussard T, Khari P, Shah N.

Kaynak‎: Transfusion 2014;54(10 Pt 2):2753-9.

İndeks‎: PubMed 24995770

DOI‎: 10.1111/trf.12723

https://www.ncbi.nlm.nih.gov/pubmed/24995770 (yeni pencere açar)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (yeni pencere açar)

Ravangard R, Mirzaei Z, Keshavarz K, Haghpanah S, Karimi M.

Kaynak‎: Hematology 2018;23(7):417-22.

İndeks‎: PubMed 29157136

DOI‎: 10.1080/10245332.2017.1404262

https://www.ncbi.nlm.nih.gov/pubmed/29157136 (yeni pencere açar)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (yeni pencere açar)

Stallworth JR, Jerrell JM, Tripathi A.

Kaynak‎: Am J Hematol 2010;85(10):795-7.

İndeks‎: PubMed 20645429

DOI‎: 10.1002/ajh.21772

https://www.ncbi.nlm.nih.gov/pubmed/20645429 (yeni pencere açar)

HEMATOLOJI VE ONKOLOJI

Maliyet tasarrufu

Türkçe

Maliyet tasarrufu

/assets/ct/fa66d95d54/images/syn_placeholder_sqr.png

Sistemli ve Çok Modlu Yaklaşım

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. (yeni pencere açar)

Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. (yeni pencere açar)

Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. (yeni pencere açar)

Anemia Management

Should intravenous iron be the standard of care in oncology? (yeni pencere açar)

Early intravenous iron administration in the Emergency Department reduces red blood cell unit transfusion, hospitalisation, re-transfusion, length of stay and costs. (yeni pencere açar)

The cost-effectiveness of treatment with erythropoietin compared to red blood cell transfusions for patients with chemotherapy induced anaemia: a Markov model. (yeni pencere açar)

Hemoglobin level at initiation of darbepoetin alfa: impact on need for transfusion and associated costs in chemotherapy-induced anemia treatment in Europe. (yeni pencere açar)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (yeni pencere açar)

Budget impact analysis on erythropoiesis-stimulating agents use for the management of chemotherapy-induced anaemia in Greece. (yeni pencere açar)

Outcomes of erythropoiesis-stimulating agents in cancer patients with chemotherapy-induced anemia. (yeni pencere açar)

Hemostatik Ajanlar

Modeling the cost-effectiveness of prothrombin complex concentrate compared with fresh frozen plasma in emergency warfarin reversal in the United Kingdom. (yeni pencere açar)

Recombinant activated factor VII use in critically ill infants with active hemorrhage. (yeni pencere açar)

İşlem/Ameliyat Sırasında Kan Koruma ve Kan Yönetimi

Restrictive blood transfusion practices are associated with improved patient outcomes. (yeni pencere açar)

Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. (yeni pencere açar)

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease. (yeni pencere açar)

Hastane İrtibat Heyeti Yerel Temsilcisiyle İletişime Geçin

Tıbbi Bilgilendirme Paketleri

Videolar

Maliyet tasarrufu

Sistemli ve Çok Modlu Yaklaşım

Anemia Management

Hemostatik Ajanlar

İşlem/Ameliyat Sırasında Kan Koruma ve Kan Yönetimi

Dilinizi Seçin